Toshihiro Fukushima Selected Research

Toshihiro Fukushima Research Topics

Disease

7	Multiple Myeloma 10/2013 - 08/2009
6	Fever (Fevers) 05/2022 - 06/2009
6	Immunoglobulin G4-Related Disease 12/2021 - 01/2012
6	Lymphoma (Lymphomas) 06/2011 - 06/2003
5	Multi-centric Castleman's Disease 05/2022 - 01/2013
5	Neoplasms (Cancer) 10/2012 - 09/2005
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2012 - 02/2002
4	Thrombocytopenia (Thrombopenia) 05/2022 - 01/2013
4	Edema (Dropsy) 05/2022 - 01/2013
3	Fibrosis (Cirrhosis) 05/2022 - 01/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 05/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2022 - 04/2012
2	Anemia 01/2019 - 12/2017
2	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 12/2017
2	Splenomegaly 12/2017 - 02/2014
2	Body Weight (Weight, Body) 09/2017 - 01/2012
2	Plasmacytoma 10/2011 - 09/2010
2	Sepsis (Septicemia) 07/2010 - 08/2009
2	Rheumatoid Arthritis 10/2007 - 01/2006
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2006 - 04/2004
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2005 - 02/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2004 - 06/2003
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021
1	Hypoalbuminemia 01/2019
1	Castleman Disease (Castleman's Disease) 12/2017
1	Vasculitis (Vasculitides) 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Febrile Neutropenia 01/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2014
1	Autoimmune Diseases (Autoimmune Disease) 02/2014
1	Residual Neoplasm 10/2013
1	Ascites 01/2013
1	Pleural Effusion (Pleural Effusions) 01/2013
1	Septic Shock (Toxic Shock Syndrome) 01/2013
1	Inflammation (Inflammations) 01/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2012
1	Philadelphia Chromosome 09/2012
1	Constipation 05/2012
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2012
1	Hepatitis 05/2012
1	Leukocytosis (Pleocytosis) 04/2012

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin G (IgG)IBA 12/2021 - 01/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 08/2009
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2003
5	Bortezomib (Velcade)FDA Link 12/2012 - 08/2009
4	C-Reactive ProteinIBA 07/2022 - 01/2013
4	Reticulin (Reticular Fiber)IBA 05/2022 - 01/2013
4	Prednisolone (Predate)FDA LinkGeneric 12/2017 - 09/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2012
3	GlucocorticoidsIBA 09/2017 - 01/2012
3	Rituximab (Mabthera)FDA Link 06/2016 - 05/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2006
3	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2012 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2017
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2016 - 10/2005
2	AntigensIBA 01/2016 - 03/2007
2	SteroidsIBA 01/2015 - 01/2013
2	CytokinesIBA 01/2015 - 05/2012
2	RNA (Ribonucleic Acid)IBA 01/2015 - 02/2006
2	LeptinIBA 02/2014 - 01/2012
2	Etoposide (VP 16)FDA LinkGeneric 01/2013 - 02/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 10/2005
2	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 10/2005
2	LipidsIBA 05/2012 - 12/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2006 - 10/2005
1	CholesterolIBA 07/2022
1	AlbuminsIBA 07/2022
1	Leucine (L-Leucine)FDA Link 12/2021
1	Blood Proteins (Serum Proteins)IBA 12/2021
1	ClusterinIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	SilverIBA 12/2021
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2016
1	tocilizumab (atlizumab)FDA Link 06/2016
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2015
1	Cladribine FDA LinkGeneric 09/2015
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 01/2015
1	CefozopranIBA 01/2015
1	Meropenem (Merrem)FDA LinkGeneric 01/2015
1	Cefepime (Maxipime)FDA LinkGeneric 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Valacyclovir (Valtrex)FDA LinkGeneric 12/2012
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2012
1	Biological ProductsIBA 10/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2012
1	Imatinib Mesylate (Gleevec)FDA Link 09/2012
1	Concanavalin AIBA 05/2012
1	phosphatidylcholine-ceramide phosphocholine transferaseIBA 05/2012
1	AclarubicinIBA 04/2012
1	AnthracyclinesIBA 04/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2012
1	Leptin ReceptorsIBA 01/2012

Therapy/Procedure

16	Therapeutics 09/2015 - 02/2002
10	Drug Therapy (Chemotherapy) 01/2013 - 02/2002
3	Remission Induction 04/2012 - 02/2002
2	Oral Administration 08/2009 - 02/2005
1	Stem Cell Transplantation 10/2013